CDC: 1,000 Food-Borne Disease Outbreaks in a Year

The latest data show that about 23,000 food-borne illnesses were reported in 2008. WebMD Health News

Diabetes Epidemic on ‘Relentlessly Upward Trajectory’

IDF and EASD leaders urge more research into ways to manage diabetes to control the escalating epidemic. Medscape Medical News

Sudden Cardiac Arrest Is More Common in Poorer Neighborhoods

The link between socioeconomic status and health outcomes, including the prevalence of cardiovascular risk factors, is well established, but little research has been completed so far on the risk of sudden cardiac arrest in poorer neighborhoods Heartwire

ASNC: Guidelines for Stress SPECT Improve Outcomes (CME/CE)

DENVER (MedPage Today) — Adherence to the appropriateness criteria for stress SPECT myocardial perfusion imaging (MPI) can lead to better utilization and outcomes, but inappropriately ordered tests offer a less useful diagnostic yield, a single-center study found.

Repeat Antibiotic Injections in Eyes Breed Resistance (CME/CE)

(MedPage Today) — Bacterial flora in eyes that were treated routinely with ophthalmic antibiotics to suppress infection after intravitreal drug injections frequently became resistant to multiple antibiotics, researchers said.

Court: Individual Mandate "Unconstitutional"

(MedPage Today) — Just a week after winning two court victories in Virginia, the Obama administration’s healthcare reform law hit a legal wall in Pennsylvania when a U.S. District Court judge ruled that forcing Americans to buy health insurance is unconstitutional.

Number of Uninsured Up Another Million

(MedPage Today) — A record 49.9 million Americans were without health insurance during 2010, up almost 2% from the 49 million uninsured in 2009, the Census Bureau reported.

HHS Aims to Save a Million Hearts

(MedPage Today) — The Obama administration today declared war on heart disease and rolled out an ambitious offensive with the stated goal of cutting the rate of heart attacks and strokes by one million events over the next five years.

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1 clinical study of VT-1161, an oral, potent and selective antifungal agent. VT-1161 is a novel small molecule discovered by Viamet Pharmaceuticals using its proprietary Metallophile Technology.

Positive data from Aeterna Zentaris’ AEZS-108 Phase 2 study on advanced endometrial cancer

Aeterna Zentaris Inc. earlier today, presented positive final Phase 2 efficacy and safety data for its targeted cytotoxic luteinizing hormone releasing hormone (LHRH) analog, AEZS-108, in advanced endometrial cancer.